Organs at risk in lung SBRT

Research output: Contribution to journalReview articlepeer-review

Abstract

Lung stereotactic body radiotherapy (SBRT) is an accurate and precise technique to treat lung tumors with high ‘ablative’ doses. Given the encouraging data in terms of local control and toxicity profile, SBRT has currently become a treatment option for both early stage lung cancer and lung oligometastatic disease in patients who are medically inoperable or refuse surgical resection. Dose-adapted fractionation schedules and ongoing prospective trials should provide further evidence of SBRT safety trying to reduce toxicities and complications. In this heterogeneous scenario, a non-systematic review of dose constraints for lung SBRT was performed, including the main organs at risk in the thorax.

Original languageEnglish
Pages (from-to)131-138
Number of pages8
JournalPhysica Medica
Volume44
DOIs
Publication statusPublished - Dec 1 2017

Keywords

  • Dose constraints
  • Lung SBRT
  • Organs at risk

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging
  • Physics and Astronomy(all)

Fingerprint Dive into the research topics of 'Organs at risk in lung SBRT'. Together they form a unique fingerprint.

Cite this